chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Did get a reaction and my hands swelled up about 20 minutes after the vaccine and my tongue swelled up; Doctor said I cannot take the 2nd dose of the vaccine; Did get a reaction and my hands swelled up about 20 minutes after the vaccine and my tongue swelled up; Doctor said I cannot take the 2nd dose of the vaccine; This is a spontaneous report from a contactable consumer (patient).  A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899 and expiration date Mar2021), via an unspecified route of administration first dose on 12Jan2021 at single dose for covid-19 immunisation. The patient's medical history included Asthma, Allergy, and Penicillin allergy. Concomitant medication included fexofenadine hydrochloride (ALLEGRA) for allergy at 180 mg, daily, budesonide (PULMICORT) for Asthma at Pulmicort is a inhaler 180, 2 puffs a day, montelukast sodium (SINGULAIR) for Asthma at 10 mg.  Historical vaccine includes Tetanus and experienced allergic reaction. Past drug includes Sulphur and experienced allergy. It was reported that the patient had the vaccine on 12Jan2021 and patient was working in long term care "administrator". The patient did get a reaction and the patient hands swelled up about 20 minutes after the vaccine and her tongue swelled up. The patient did take Benadryl. The patient called her primary care doctor and was told to stay on the Benadryl and the patient was okay. The patient stated that the pharmacist that gave her the vaccine gave the Benadryl right away when the patient started swelling up.  The patient spoke to her allergist and stated that she cannot take the second dose vaccine. So, the patient was concerned about her coverage because she work in a long term case. The doctor would not give me the shingle vaccine (unspecified vaccine) because they were afraid the patient would have a reaction to that.  The outcome of the events was unknown.
Shingles on both my arms, my legs and my elbows; Left purple scars; Lesions; Purple scars; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included shingles vaccine with an associated reaction of herpes zoster (received roughly 20 years ago from reporting).   On an unknown date, the patient received the 1st dose of Shingrix (left arm). In AUG-2023, 1 week after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles on both my arms, my legs and my elbows), scar (Verbatim: Left purple scars) and skin discoloration (Verbatim: Purple scars). On an unknown date, the patient experienced skin lesion (Verbatim: Lesions).  In AUG-2023, the outcome of the shingles, scar and skin discoloration were resolved. The outcome of the skin lesion was resolved.   It was unknown if the reporter considered the shingles, scar, skin lesion and skin discoloration to be related to Shingrix.     It was unknown if the company considered the shingles, scar, skin lesion and skin discoloration to be related to Shingrix.   Additional Information: Receipt date: 21-AUG-2023 and 22-AUG-2023 The patient reported that he had a 1 shingle for 33 years. It comes and goes due to stress. Like the butterball thermometer in a turkey.  When the first shingle shot vaccine came out, he got one and never had any effect on his butterball thermometer.  Now the patient received Shingrix about 3 weeks ago from reporting and approximately 7 days later he got shingles on both arms, legs and elbows. Left purple scars where they popped up.  The lesions had cleared up and the consumer did not go to his doctor.  The patient stated that this was the result of shingles.  Now the patient questioning if the second shot is worth it, did use a live virsus, would he get it worse with the second shot. The patient states that his dermatology appointment on 17th October 2023. The reporter consented to follow up. Consent to follow up with dermatologist was obtained.
Hospitalization for acute hypoxemic respiratory failure due to COVID. Treated with barcitinib, dexamethasone, Remdesivir.
Patient experienced vasovagal syncope after receiving both vaccinations lasting less than 1 minute.
(L) arm redness & swelling after recent DTAP. Advised cool compresses, BENADRYL prn itching & ibuprofen prn pain.
Expired Shingrix administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number FZ7Z4, expiry date 27-JAN-2023) for prophylaxis.   On 23-MAR-2023, the patient received Shingrix. On 23-MAR-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Expired Shingrix administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 24-MAR-2023 The reporter was a physician assistant. The reporter reported that the patient received expired Shingrix vaccine and wanted to know how to proceed with the patient. The reporter did consent to follow up. The patient received a Shingrix vaccine which was already expired, which led to expired vaccine used.
Administrated / an expired dose of Infanrix /  expired on October 23 2020; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 1-year-old female patient who received DTPa (Infanrix) (batch number cx59c, expiry date 23rd October 2020) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th July 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 14th July 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The manager reported that, the patient administrated with an expired dose of Infanrix, which led to expired vaccine used. The vaccine expired on 23rd October 2020. No adverse event was reported. The reporter consented to follow up.
Child got up with light red raised rash on face. Mom and child came to health dept at 10:00 am. rash now spread to legs, upper back, and both arms. Child's private physician not in office today. Instructed to take child to walk-in clinic at nearby physicians complex. TC received from mom late in day. Physician gave prescription medication (Vistaril). (Child is asthmatic and could not take Benadryl.) Child has no temp. but has wanted to scratch at arms and legs. One dose of medication administered by mom, 08/12/2002: TC to residence. Rash almost completely gone. 08/14/2002: TC to residence, child ok.
"My arm was sore for the first 24 hours, but the next morning I noticed that my hands were red.  Otherwise I just felt tired, and my skin felt hypersensitive"
Pounding headache. Chills. Joint aches muscle aches body aches fatigue
Rapid onset of Guillain-Barre. Quadriplegia, Decubitus Ulcer, tracheotomy acute respiratory failure (has regained partial respiration), Gastrostomy tube IGIV treatment, Plasmapheresis, high dose steroids.
was delirious/talked out of head; fever; slept often; Initial information regarding an unsolicited valid serious case was received from a consumer (patient) via social media  on 08-Dec-2020.  This case involves a patient of unknown demographics who was delirious/talked out of head (delirium), had fever (pyrexia) and slept often (hypersomnia), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was delirious, had talked out of head (delirium) (unknown latency) following the administration of INFLUENZA VACCINE. The event delirious was assessed as medically significant as per important medical event (IME) list.  On an unknown date, the patient had fever (pyrexia) and slept often (hypersomnia),(non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.   It was reported as the patient had taken vaccine during college days in 1976 and was totally out of it for 7 days. Patient list wright from not eating but never had the flu since getting that vaccine. The patient was too afraid and not taking flu shot at all.  No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information available on the batch number for this case.
Patient with severe dementia developed nausea, dizziness and diaphoresis; acute distress. No chest pain or dyspnea noted.  3:49 P 56, 144/78,  PO2 99% 3:54 P 34 164/58, O2 99% Exam CVS- irregular rhythm, systolic ejection murmur Care taken over by EMS and transported to  Hospital
Moderna vaccine was administered outside of Facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------------------- I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 5/15/2021 ACUTE ST ELEVATION MI, UNSPECIFIED I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 5/16/2021 ACUTE ST ELEVATION MI, UNSPECIFIED I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 5/15/2021 ACUTE CORONARY SYNDROME, UNSPECIFIED    CKD STAGE 4 (GFR 15-29) I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 5/16/2021 ACUTE CORONARY SYNDROME, UNSPECIFIED    CKD STAGE 4 (GFR 15-29) I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 5/15/2021 HX OF ST ELEVATION MI I24.9 ACUTE CORONARY SYNDROME, UNSPECIFIED 5/16/2021 HX OF ST ELEVATION MI
8PM - Night of receiving Vaccine - Slight back pain - Took 800mg Ibuprofen Next Day 2 AM - Woke up with severe Muscle spasms in middle back area - Bad Pain for 15-20 minutes - Took more ibuprofen 6 AM - Woke up with severe Muscle spasms in middle back area - Bad Pain for 15-20 minutes - Took more ibuprofen Next Day 6 AM - Woke up with severe Muscle spasms in middle back area - Bad Pain for 15-20 minutes - Took more ibuprofen Every Morning - Next 3 weeks (ongoing) Back Pain around 5:30 am each morning (Mild discomfort)
Small area of hives behind armpits bilateral. This was not that bothersome. Also impressive pain at injection site. Both hives and pain developed the following day (approx 12 hrs later). Pain resolved after 1 day with topical ice and arnica. Hives resolved after 2 days with topical otc hydrocortisone. I was disqualified from second vaccine due to hives.
Information has been received from a registered nurse concerning a 6-year-old female who in approximately October 2005 was vaccinated with one dose of Varivax. Subsequently, the patient was diagnosed with shingles. There was no product quality complaint. Unspecified medical attention was sought. The outcome was recovered. There was no further information to report. Additional information has been requested.
Pain radiating to my back; Night sweats; Severely swollen Lymph Nodes with pain radiating to my back.; Severe chills; probably fever; This is a spontaneous report from a contactable patient. A 51-year-old non- pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN), via an unspecified route of administration on left arm on an unknown date in Mar2021 at 12:30 (at the age of 51-years-old), as single dose for COVID-19 immunisation. Medical history included high cholesterol and anxiety started on an unknown date. The patient's known allergy to sulfa meds and hazel nuts. Concomitant medications included Montelukast Sodium (SINGULAIR), Sertraline (ZOLOFT), Levothyroxine (MANUFACTURER UNKNOWN), Lovastatin (MANUFACTURER UNKNOWN); all for unknown indication, from unknown dates and unknown if ongoing. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient did not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. On 17Mar2021 at 10:00, the patient experienced severely swollen lymph nodes with pain radiating to the back. The patient also experienced severe chills and night sweats (probably a fever but didn't take temp). The patient did not receive any treatments for the events. The clinical outcome of the events severely swollen lymph nodes with pain radiating to the back, severe chills, night sweats, probably fever was recovering at the time of reporting.   Information about lot number cannot be obtained. No further information is expected.
Information has been received from a consumer concerning her 37 year old son with immune system disorder who in approximately August 2009, "about a month ago" was vaccinated with a single dose of ATTENUVAX. Sometimes last week, the patient developed staph infection, strep throat and scarlet fever. The patient saw his physician and was given anti-biotics (name and manufacturer unspecified). It was reported that the reporter did not know if the vaccine caused the patient to have these experiences. At the time of the report, the patient's status was unknown. No further information is available.
Noted red spot, red blotchy not size of golf ball - hot/warm to touch.  Advised apply cool compress with gentle message.
Approx 30 min p/MMR vax pt devel hives, inc mucous from nose; on auscultation pt was wheezing;
pt recvd vax 2MAR96;3MAR95 0600 devel severe ha/, myalgias, malaise & joints aching;also local soreness @ inj site;BP 100/70, P80, R20, T98.9;pt relieved of duty and driven home by friend
Pt received a vaccine of Johnson and Johnson (Janssen) Covid-19 vaccine. She asked if it was normal that her arm hurt really bad, then she stated she was getting dizzy and light headed. I instructed her to sit on the floor so she would not fall down. She sat on the floor and immediately passed out. She remained unconscious for 60- 90 seconds. We laid her into the prone position. Her arms were twitching. She regained consciousness. 911 was alerted and responded. Pt refused to leave with them. She sat with un an additional 15 minutes before she left for a therapy appointment.
Received shot 12/4/03 about 3:00 PM. No reaction at that time. 12/5/03 awoke in AM with headache and feeling "flush". Approx 9-9:30 noticed hives to arms (due to itching). Took Benadryl 50mg and went home. Called Infection Control and private MD.
ARM SWOLLEN AND TURNED HARD AND RED. SEVERE ITCHING NO REPORTS OF HIVES OR BREATHING PROBLEMS.
Pt recvd 3 hep B vax doses given 1AUG89, 31AUG89, & 23JAN90 following these titer=68; p/1 yr titer=2;
Initial Events - started morning 2/15/21 - dizziness, lightheadedness, fatigue, nausea, chills - resolved by 6pm 2/16/21.  Subsequent Event - started morning 2/16/21 - leg pain in calf area and formation of lump in armpit of right arm.  Leg pain migrating to upper rear of legs and into lower back  from 2/16/21 to 2/18/21.  These events are ongoing and unresolved.
Pfizer 4/6, 4/27, and 12/22. Positive on 12/30
Per family and health department report, patient died at home. No treatment or assessment performed. Patient family reports death caused by complications r/t bladder cancer. No further details released.
On June 15, I was admitted to the hospital with a saddle pulmonary embolism.  I had to have surgery to remove the clots from my heart and both lungs.  We have exhausted all possibilities of how this may have occurred including cancer, hereditary and excessive red blood cells. I am now taking a blood thinner - warfarin and metapropolol (beta blocker) for my heart rate. Went back to the emergence room July 30th 2021 due to swollen calf and ankle and determined I have 3 blood clots in my hip and calf. Having to take shots in my stomach now to supplement Warfarin.
Anaphylaxis within 5 min of injection. Treated with 2 doses Epi pen, IM Benadryl 50. Transferred via ambulance to ED. More drugs Decameron, Pepcid. Observed 6 hours. Discharged to home with instructions and meds Benadryl and Pepcid. Recovering at home.
Site: Swelling at Injection Site-Severe, Systemic: Fever-Medium, Additional Details: Site of injection looks like a burn. It has gotten hot and inflammed and is blistering.  Some of the blisters have burst others are oozing.
4 days after 1st dose severe abdominal bloating and daily abnormal loose stools.  A few days after 2nd dose severe, frequent diarrhea up to 10-13 times a day and severe abdominal pain. Unable to eat solid foods for 3 weeks.  I was reduced to wearing a disposable undergarment and drinking nutritional shakes 3x a day for 3 weeks. Pain was unbearable for a period of 3 weeks from 2-17-21 to 3-3-13-21. Overall symptoms lasted a total of 4 months with a few short episodes to date of this form.
Vaccination site soreness; Vaccination site erythema; This spontaneous report has been received from a physician via Pfizer, regarding a female patient of unknown age. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection as prophylaxis (strength, dose, scheme, route and anatomical location of administration, lot number and expiration date were not reported).  On an unspecified date, the patient experienced erythema and soreness, but there was no general anaphylaxis nor anything similar (vaccination site erythema, vaccination site pain). The reporter stated he did not know if the reaction could have been related to the antigens of the vaccine, or if it was completely separate, and was regarding if there was any information regarding of it as he wanted to administer PNEUMOCOCCAL VACCINE CONJ 20V (CRM197) (PREVNAR20) to the patient. The outcome of the events was not reported.  The causal relationship between vaccination site erythema and vaccination site pain and Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was unknown.
PERIPHERAL NEUROPATHY  4/4/2022 -- RECURRENCE OF SAME SYMPTOMS
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen) was received from a mother regarding her 6-year-old son who experienced fever up to 104.3 F, cold symptoms, runny nose, cough, loss of appetite and eye redness. At 6 years of age, the patient received a dose on 13-Dec-2003. Medical History: The patient had no relevant medical history. Product Details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 13-Dec-2003. Dose regiment was 0.5 mL (intranasal). Concomitant Therapy: Concomitant medication were not reported. Event Details: On 16-Dec-2003, 3 days post-immunization, the child began to have a high fever 101-102 F., cold symptoms, runny nose, cough, and his eyes became red. His fever went as high as 104.3 F. He was seen by the pediatrician, and diagnostic test (see below) were within normal limits. As of 23-Dec-2003, the child's fever was 102 F., his eyes had cleared, but he still had a cough, runny nose and loss of appetite. Test results: His chest x-rays and complete blood count were clear and strep test was negative. No additional information was available at the time of this report.
The patient developed Hepatitis A. The patient sought unspecified medical attention. IN FOLLOW-UP information, the reporter stated "that the patient was treated and recovered, however he couldn't confirm if the patient had Hepatitis A". FOLLOW-UP information from the medical records, dated 12/18/00, indicated that the patient was a 59- year old female whoi has longstanding diabetes and was taking glimepirade (Amaryl) and Metformin hydrochloride(Glucophage). It was also indicated that she recntly had an area in breast taken out which showed a caricinoma in situ and was getting "tamoxifen" as a prophylaxis. Her liver enzymes were all normal on 03/20/00.The physician indicated that the patient developed some sort of "ill understood" syndrome of fever, chills and jaundice around 11/18/00. The patient's  bilirubin went up to 10.3 mg/dl. Her alkaline phosphatases were up to around 460 U/L on 11/20/00 and her SGPT and SGOT were at 150 and 81 U/L respectively. Her Hepatitis panel was unremarkable, just showing an old proctective IgG antibody to help Hepatitis A virus  but no acute  antibody. Her liver enzymes gradually drifted down to normal by 12/04/00. Her alkaline phosphatases were down to 175 and SGOT and SGPT were normal. Her bilirubin  was back down to 1.5. She never had any pain and never had any pruritus. she only had the fever and chills for a  couple days. She was not taking any new medications during this period of time. The patient had a liver/spleen scan which showed a normally functioning and normal sized liver and spleen with no filling defects. The patient had a CT scan done on 11/20/00 , to rule out obstruction, and the liver and spleen were both normal in size, and no focal abnormalities were seen. There were some coincidental radiologic abnormality (possible artifact) was seen with some dilated tortuous veins around the spleen, and these were confluent with the left gonadal veins on the iliac crest. The physician indicated that the patient's physical examination revealed no sclerae icterus and a normal abdominal examination. The physician indicated that the patient had acute intrahepatic cholestasis which may have been of a viral etiology and had resolved. The physician stated "she doe not appear to have cirrhosis. She did not have a typical A,B or C acute Hepatitis, and this may have been related to some other virus as regards to the syndrome of fever, chills and acute development of jaundice that she experienced on 11/18/00". Abnormal labs from 11/20/00 included :glucose: 204 mg/dl; alkaline phosphate: 460 U/L; SGOT: 81 U/L; SGPT:150 U/L; T. bilirubin; 7:3 mg/dl; anti-HAV AB: positive.
This case was reported by a physician via sales rep and described the occurrence of fever in a male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included diabetes. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved. The reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician stated that the patient had 102 Fahrenheit fever lasting 1 day, which resolved on its own and believed it was related to the vaccine. The physician did agree to follow up from GlaxoSmithKline.